Q3 2015 Sales $19.0mm (+12% organic), Record Op. Inc. $3.3mm (+79%)
BURLINGTON, Mass., Oct. 27, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q3 2015 results, announced a $0.04/share dividend and provided guidance.
Q3 2015 results included: •Sales of $19.0mm, +9% reported (+12% organic) vs. Q3 2014 •Record operating income of $3.3mm vs. $1.9mm, +79% •Record operating margin of 17% •Record net income of $2.1mm vs. $0.9mm, +124% •Earnings of $0.11 per diluted share vs. $0.05, +115% •Record EBITDA of $4.0mm vs. $2.7mm, +47% •Cash increased $4.2mm to $23.6mm
LeMaitre Q1 top line up 8%; earnings up 20%; EPS guidance raised; shares down 17% on softer sales guidance Apr. 26, 2018 10:05 AM ET|About: LeMaitre Vascular, Inc. (LMAT)|By: Douglas W. House, SA News Editor
Thinly traded small cap LaMaitre Vascular (LMAT -16.5%) is down on more than double normal volume, albeit on turnover of only 331K shares, in response to its Q1 results and softer sales guidance.
02/06/2020 | 05:27pm EST BURLINGTON, Mass. (AP) _ LeMaitre Vascular Inc. (LMAT) on Thursday reported fourth-quarter net income of $4.6 million. On a per-share basis, the Burlington, Massachusetts-based company said it had net income of 23 cents. The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 23 cents per share. The medical device maker posted revenue of $30.2 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $30.5 million. For the year, the company reported profit of $17.9 million, or 88 cents per share. Revenue was reported as $117.2 million. For the current quarter ending in April, LeMaitre expects its per-share earnings to range from 14 cents to 17 cents. The company said it expects revenue in the range of $30.5 million to $31.7 million for the fiscal first quarter. LeMaitre expects full-year earnings in the range of 90 cents to 98 cents per share, with revenue ranging from $127.4 million to $130.8 million.
06/22/2020 | 09:13pm BST BURLINGTON, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5 million in cash paid at closing ($65.0 million to Artegraft plus $7.5 in escrow to be released December 31, 2021) as well as potential earnout payments of $17.5 million payable based upon future sales of the acquired business. Under the terms of the deal, LeMaitre will continue to operate Artegraft’s manufacturing facility in North Brunswick, NJ for at least three and a half years and will retain most of Artegraft’s employees, including seven sales & marketing personnel.